Contrast-enhanced harmonic endoscopic ultrasonography in pancreatic diseases

Can Xu, Zhaoshen Li, Michael Wallace

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Endoscopic ultrasonography (EUS) is the most sensitive imaging method for diagnosis of pancreatic tumors. However, it still has limits in the differentiation between pancreatic cancers and inflammatory tumor-like masses. A novel technology, contrast-enhanced harmonic EUS (CH-EUS), has been developed recently. It can visualize both parenchymal perfusion and microvasculature in pancreas without Doppler-related artifacts. Therefore, it is superior to EUS and CT in detecting small pancreatic masses and differential diagnosis of pancreatic masses. CH-EUS could be used for adequate sampling of pancreatic tumors and may predict the pathological features of the pancreatic solid lesions but still cannot replace EUS-FNA now.

Original languageEnglish (US)
Article number786239
JournalDiagnostic and Therapeutic Endoscopy
DOIs
StatePublished - 2012

Fingerprint

Pancreatic Diseases
Endosonography
Neoplasms
Microvessels
Pancreatic Neoplasms
Artifacts
Pancreas
Differential Diagnosis
Perfusion
Technology

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Contrast-enhanced harmonic endoscopic ultrasonography in pancreatic diseases. / Xu, Can; Li, Zhaoshen; Wallace, Michael.

In: Diagnostic and Therapeutic Endoscopy, 2012.

Research output: Contribution to journalArticle

@article{971ce2f20efe4f34a28af665babaad8a,
title = "Contrast-enhanced harmonic endoscopic ultrasonography in pancreatic diseases",
abstract = "Endoscopic ultrasonography (EUS) is the most sensitive imaging method for diagnosis of pancreatic tumors. However, it still has limits in the differentiation between pancreatic cancers and inflammatory tumor-like masses. A novel technology, contrast-enhanced harmonic EUS (CH-EUS), has been developed recently. It can visualize both parenchymal perfusion and microvasculature in pancreas without Doppler-related artifacts. Therefore, it is superior to EUS and CT in detecting small pancreatic masses and differential diagnosis of pancreatic masses. CH-EUS could be used for adequate sampling of pancreatic tumors and may predict the pathological features of the pancreatic solid lesions but still cannot replace EUS-FNA now.",
author = "Can Xu and Zhaoshen Li and Michael Wallace",
year = "2012",
doi = "10.1155/2012/786239",
language = "English (US)",
journal = "Diagnostic and Therapeutic Endoscopy",
issn = "1070-3608",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Contrast-enhanced harmonic endoscopic ultrasonography in pancreatic diseases

AU - Xu, Can

AU - Li, Zhaoshen

AU - Wallace, Michael

PY - 2012

Y1 - 2012

N2 - Endoscopic ultrasonography (EUS) is the most sensitive imaging method for diagnosis of pancreatic tumors. However, it still has limits in the differentiation between pancreatic cancers and inflammatory tumor-like masses. A novel technology, contrast-enhanced harmonic EUS (CH-EUS), has been developed recently. It can visualize both parenchymal perfusion and microvasculature in pancreas without Doppler-related artifacts. Therefore, it is superior to EUS and CT in detecting small pancreatic masses and differential diagnosis of pancreatic masses. CH-EUS could be used for adequate sampling of pancreatic tumors and may predict the pathological features of the pancreatic solid lesions but still cannot replace EUS-FNA now.

AB - Endoscopic ultrasonography (EUS) is the most sensitive imaging method for diagnosis of pancreatic tumors. However, it still has limits in the differentiation between pancreatic cancers and inflammatory tumor-like masses. A novel technology, contrast-enhanced harmonic EUS (CH-EUS), has been developed recently. It can visualize both parenchymal perfusion and microvasculature in pancreas without Doppler-related artifacts. Therefore, it is superior to EUS and CT in detecting small pancreatic masses and differential diagnosis of pancreatic masses. CH-EUS could be used for adequate sampling of pancreatic tumors and may predict the pathological features of the pancreatic solid lesions but still cannot replace EUS-FNA now.

UR - http://www.scopus.com/inward/record.url?scp=84870199897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870199897&partnerID=8YFLogxK

U2 - 10.1155/2012/786239

DO - 10.1155/2012/786239

M3 - Article

JO - Diagnostic and Therapeutic Endoscopy

JF - Diagnostic and Therapeutic Endoscopy

SN - 1070-3608

M1 - 786239

ER -